These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 4650857)

  • 21. Therapeutic effect of 5-hydroxytryptamine antagonists on inherited muscular dystrophy in the chicken and hamster [proceedings].
    Barnard EA; Barnard PJ
    J Physiol; 1978 May; 278():29P-30P. PubMed ID: 671302
    [No Abstract]   [Full Text] [Related]  

  • 22. Recovery of induced mutations for X chromosome-linked muscular dystrophy in mice.
    Chapman VM; Miller DR; Armstrong D; Caskey CT
    Proc Natl Acad Sci U S A; 1989 Feb; 86(4):1292-6. PubMed ID: 2919177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arginine butyrate: a therapeutic candidate for Duchenne muscular dystrophy.
    Vianello S; Yu H; Voisin V; Haddad H; He X; Foutz AS; Sebrié C; Gillet B; Roulot M; Fougerousse F; Perronnet C; Vaillend C; Matecki S; Escolar D; Bossi L; Israël M; de la Porte S
    FASEB J; 2013 Jun; 27(6):2256-69. PubMed ID: 23430975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment with soluble activin type IIB-receptor improves bone mass and strength in a mouse model of Duchenne muscular dystrophy.
    Puolakkainen T; Ma H; Kainulainen H; Pasternack A; Rantalainen T; Ritvos O; Heikinheimo K; Hulmi JJ; Kiviranta R
    BMC Musculoskelet Disord; 2017 Jan; 18(1):20. PubMed ID: 28103859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug evaluation in muscular dystrophy of the chicken.
    Entrikin RK; Patterson GT; Wilson BW
    Muscle Nerve; 1982 Apr; 5(4):321-7. PubMed ID: 7099198
    [No Abstract]   [Full Text] [Related]  

  • 26. Enhanced autophagy as a potential mechanism for the improved physiological function by simvastatin in muscular dystrophy.
    Whitehead NP
    Autophagy; 2016; 12(4):705-6. PubMed ID: 26890413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteinase inhibitors and muscle degeneration.
    Stracher A
    Muscle Nerve; 1982; 5(6):494. PubMed ID: 7133046
    [No Abstract]   [Full Text] [Related]  

  • 28. Pentoxifylline fails to attenuate fibrosis in dystrophic (mdx) diaphragm muscle.
    Gosselin LE; Williams JE
    Muscle Nerve; 2006 Jun; 33(6):820-3. PubMed ID: 16502423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dysferlin deletion in SJL mice (SJL-Dysf) defines a natural model for limb girdle muscular dystrophy 2B.
    Bittner RE; Anderson LV; Burkhardt E; Bashir R; Vafiadaki E; Ivanova S; Raffelsberger T; Maerk I; Höger H; Jung M; Karbasiyan M; Storch M; Lassmann H; Moss JA; Davison K; Harrison R; Bushby KM; Reis A
    Nat Genet; 1999 Oct; 23(2):141-2. PubMed ID: 10508505
    [No Abstract]   [Full Text] [Related]  

  • 30. Bortezomib Does Not Reduce Muscular Dystrophy in the dy2J/dy2J Mouse Model of Laminin α2 Chain-Deficient Muscular Dystrophy.
    Körner Z; Durbeej M
    PLoS One; 2016; 11(1):e0146471. PubMed ID: 26731667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dysferlin-deficient muscular dystrophy: gadofluorine M suitability at MR imaging in a mouse model.
    Schmidt S; Vieweger A; Obst M; Mueller S; Gross V; Gutberlet M; Steinbrink J; Taubert S; Misselwitz B; Luedemann L; Spuler S
    Radiology; 2009 Jan; 250(1):87-94. PubMed ID: 19001151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Four-week rapamycin treatment improves muscular dystrophy in a fukutin-deficient mouse model of dystroglycanopathy.
    Foltz SJ; Luan J; Call JA; Patel A; Peissig KB; Fortunato MJ; Beedle AM
    Skelet Muscle; 2016; 6():20. PubMed ID: 27257474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imatinib mesylate ameliorates the dystrophic phenotype in exercised mdx mice.
    Bizario JC; Cerri DG; Rodrigues LC; Oliveira GL; Nomizo A; de Araujo DD; Fukuhara PS; Ribeiro JC; de Castro FA; Costa MC
    J Neuroimmunol; 2009 Jul; 212(1-2):93-101. PubMed ID: 19508953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thyroxine reverses deficits of nerve growth factor and epidermal growth factor in submandibular glands of mice with muscular dystrophy.
    Watson AY; Radie K; McCarthy M; Larsen PR; Murphy RA
    Endocrinology; 1982 Apr; 110(4):1392-401. PubMed ID: 6977440
    [No Abstract]   [Full Text] [Related]  

  • 35. Positive effects of bisphosphonates on bone and muscle in a mouse model of Duchenne muscular dystrophy.
    Yoon SH; Sugamori KS; Grynpas MD; Mitchell J
    Neuromuscul Disord; 2016 Jan; 26(1):73-84. PubMed ID: 26494410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucocorticoids and immunosuppressants do not change the prevalence of necrosis and regeneration in mdx skeletal muscles.
    Weller B; Massa R; Karpati G; Carpenter S
    Muscle Nerve; 1991 Aug; 14(8):771-4. PubMed ID: 1891001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved muscle strength and mobility in the dy(2J)/dy(2J) mouse with merosin deficient congenital muscular dystrophy treated with Glatiramer acetate.
    Dadush O; Aga-Mizrachi S; Ettinger K; Tabakman R; Elbaz M; Fellig Y; Yanay N; Nevo Y
    Neuromuscul Disord; 2010 Apr; 20(4):267-72. PubMed ID: 20304648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of prednisone in canine muscular dystrophy.
    Liu JM; Okamura CS; Bogan DJ; Bogan JR; Childers MK; Kornegay JN
    Muscle Nerve; 2004 Dec; 30(6):767-73. PubMed ID: 15468337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of white muscle disease.
    Morel AM
    Vet Rec; 1979 Mar; 104(12):269. PubMed ID: 473511
    [No Abstract]   [Full Text] [Related]  

  • 40. Gentamicin fails to increase dystrophin expression in dystrophin-deficient muscle.
    Dunant P; Walter MC; Karpati G; Lochmüller H
    Muscle Nerve; 2003 May; 27(5):624-7. PubMed ID: 12707984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.